drugset / Trial / NCT05324163
Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is a randomized, double-blind clinical trial in a Chinese population
Timeline
- Start
- 2021-09-29
- Primary completion
- 2023-02-06
- Completion
- 2023-02-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Celecoxib | Other / unclassified | 200 mg | — |
| Subject | IBUPROFEN TRELAMINE | Small molecule | 17.5 mg | — |